Amnesia as an Adverse Event Associated With Fentanyl: An Analysis of the US Food and Drug Administration Adverse Event Reporting System, 2011-2021.

Abstract

*Department of Medicine, Soldiers’ Home, Chelsea ‡Massachusetts Department of Public Health, Jamaica Plain, MA †Department of Anesthesiology and Critical Care, University of Pennsylvania School of Medicine, Philadelphia, PA W.A.K.: funded by 1R01NS082309-01A1. Serves as a legal consultant for multiple legal and health care entities. Receives royalty payments Oxford University Press and Elsevier, as well as honoraria from National Institutes of Health study sections. Serves on editorial boards for Neurocritical Care and Journal of Neurosurgical Anesthesiology. Coauthored provisional patent number 17-8261/103241.000816 Trustees of the University of Pennsylvania. The remaining authors have no conflicts of interest to declare. Address correspondence to: Jed A. Barash, MD, Department of Medicine, Soldiers' Home, 91 Crest Avenue, Chelsea, MA 02150; telephone: (617) 884-5660; e-mail: [email protected]